Related Experiment Video
Updated: Aug 2, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid
S Sharpe1, K R Barber, C W Grant
1Department of Biochemistry, University of Western Ontario, London, Canada.
Abstract:
Certain point mutations within the hydrophobic transmembrane domains of class I receptor tyrosine kinases have been associated with oncogenic transformation in vitro and in vivo [Gullick, J., and Srinivasan, R. (1998) Breast Cancer Res. Treat. 52, 43-53]. An important example is the replacement of a single (hydrophobic) valine by (charged) glutamate in the rat protein, Neu, and in the homologous human protein, ErbB-2. It has been suggested that the oncogenic nature of this Val-->Glu substitution may derive from alteration of the transmembrane domain's ability to take part in direct side-to-side associations. In the present work, we examined the basis of this phenomenon by studying transmembrane portions of ErbB-2 in fluid bilayer membranes. An expression system was designed to produce such peptides from the wild-type ErbB-2, and from an identical region of the transforming mutant in which Val(659) is replaced by Glu. All peptides were 50-mers, containing the appropriate transmembrane domain plus contiguous stretches of amino acids from the cytoplasmic and extracellular domains. Deuterium heteronuclear probes were incorporated into alanine side chains (thus, each alanine -CH(3) side chain became -CD(3)). Given the presence of natural alanine residues at positions 648 and 657 within ErbB-2, this approach afforded heteronuclear probes within the motif Ser(656)AlaValValGlu(660), thought to be important for homodimer formation, and nine residues upstream of this site. Further peptides were produced, by site-directed mutagenesis, to confirm spectral assignments and to provide an additional probe location at position 670 (11 residues downstream of the motif region). On SDS-polyacrylamide gels, the transmembrane peptides migrated as predominant monomers in equilibrium with smaller populations of homodimers/-oligomers. CD spectra of both wild-type and transforming mutant peptides were consistent with the transmembrane portions being basically alpha-helical. (2)H NMR spectra of each transmembrane peptide were obtained in fluid phospholipid bilayers of 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) from 35 to 65 degrees C. Results were consistent with the concept that the glutamic acid residue characterizing the mutant is uncharged at neutral pH. Narrowed spectral components from species rotating rapidly and symmetrically within the membrane appeared to represent monomeric peptide. Mutation of Val(659) to Glu within the hydrophobic domain induced changes in side chain angulation of at least 6-8 degrees at Ala(657) (i.e., within the five amino acid motif thought to be involved in homodimer formation), and downstream of this site to residue 670. There was little evidence of effect at the upstream site (Ala(648)) at the membrane surface. This result argues that the transforming mutation is associated with significant intramolecular rearrangement of the monomeric transmembrane helix-extending over some four helix turns-which could influence its lateral associations. In addition, temperature effects on spectral quadrupole splittings suggested that there is greater peptide backbone flexibility for the wild-type transmembrane region.
Insights
The Val659Glu mutation in ErbB-2 transmembrane domain alters helix structure, affecting receptor dimerization and oncogenic transformation. This study reveals intramolecular rearrangements in the mutant transmembrane helix.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Point mutations in receptor tyrosine kinase transmembrane domains, like Val->Glu in ErbB-2, are linked to oncogenic transformation.
- The Val659Glu substitution in ErbB-2 is hypothesized to promote cancer by altering transmembrane domain associations.
Purpose of the Study:
- To investigate the structural basis of the oncogenic Val659Glu mutation in the ErbB-2 transmembrane domain.
- To analyze how this mutation affects peptide associations within fluid bilayer membranes.
Main Methods:
- Produced wild-type and mutant ErbB-2 transmembrane peptides (50-mers) with deuterium probes.
- Utilized SDS-PAGE, Circular Dichroism (CD) spectroscopy, and 2H Nuclear Magnetic Resonance (NMR) in phospholipid bilayers.
- Employed site-directed mutagenesis to confirm spectral assignments and probe locations.
Main Results:
- Peptides existed as monomers in equilibrium with dimers/oligomers; CD spectra indicated alpha-helical structures.
- 2H NMR revealed the mutant's Glu659 is uncharged at neutral pH and induces significant side chain angulation changes (6-8 degrees) at Ala657 and downstream residues.
- The mutation caused intramolecular rearrangements in the transmembrane helix, affecting potential lateral associations, while wild-type showed greater backbone flexibility.
Conclusions:
- The Val659Glu mutation induces substantial intramolecular structural changes within the ErbB-2 transmembrane helix.
- These rearrangements likely influence receptor dimerization and contribute to the oncogenic potential of ErbB-2.
- The study provides structural insights into how transmembrane domain mutations drive receptor tyrosine kinase-associated cancers.
More Related Videos
04:47Measuring Transcellular Interactions through Protein Aggregation in a Heterologous Cell System
Published on: May 22, 2020
09:58An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence
Published on: May 2, 2025